Circular RNA in cervical cancer: Fundamental mechanism and clinical potential

Sema Begliarzade; Albert Sufianov; Tatiana Ilyasova; Alina Shumadalova; Rinat Sufianov; Ozal Beylerli; Zhongrui Yan

doi:10.1016/j.ncrna.2023.11.009

Circular RNA in cervical cancer: Fundamental mechanism and clinical potential

Noncoding RNA Res. 2023 Nov 18;9(1):116-124. doi: 10.1016/j.ncrna.2023.11.009. eCollection 2024 Mar.

Authors

Sema Begliarzade¹, Albert Sufianov^{2

3}, Tatiana Ilyasova⁴, Alina Shumadalova⁵, Rinat Sufianov^{3

6}, Ozal Beylerli⁷, Zhongrui Yan⁸

Affiliations

¹ Department of Oncology, Radiology and Radiotherapy, Tyumen State Medical University, 54 Odesskaya Street, 625023, Tyumen, Russia.
² Educational and Scientific Institute of Neurosurgery, Рeoples' Friendship University of Russia (RUDN University), Moscow, Russia.
³ Department of Neurosurgery, Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.
⁴ Department of Internal Diseases, Bashkir State Medical University, Ufa, Republic of Bashkortostan, 450008, Russia.
⁵ Department of General Chemistry, Bashkir State Medical University, Ufa, Republic of Bashkortostan, 3 Lenin Street, 450008, Russia.
⁶ Department of Neurooncology, N. N. Blokhin National Medical Research Center of Oncology, Ministry of Health of the Russian Federation, Moscow, Russia.
⁷ Central Research Laboratory, Bashkir State Medical University, Ufa, Republic of Bashkortostan, 3 Lenin Street, 450008, Russia.
⁸ Department of Gynecology, Tianjin Baodi Hospital, Baodi Clinical College of Tianjin Medical University, Tianjin, 301800, China.

Abstract

CC (CC) remains a significant global health concern, imposing a substantial health burden on women worldwide due to its high incidence and mortality rates. To address this issue, there is a need for ongoing research to uncover the underlying molecular mechanisms of CC and to discover novel diagnostic and therapeutic strategies. Recent progress in non-coding RNAs (ncRNAs) has opened new avenues for investigation, and circular RNAs (circRNAs) have emerged as molecules with diverse roles in various cellular processes. These circRNAs are distinct in structure, forming a closed loop, setting them apart from their linear counterparts. They are intricately involved in regulating different aspects of cellular functions, particularly in cell growth and development. Remarkably, circRNAs can have varying functions, either promoting or inhibiting oncogenic processes, depending on the specific cellular context. Recent studies have identified abnormal circRNAs expression patterns associated with CC, indicating their significant involvement in disease development. The differing circRNAs profiles linked to CC present promising opportunities for early detection, precise prognosis evaluation, and personalized treatment strategies. In this comprehensive review, we embark on a detailed exploration of CC-related circRNAs, elucidating their distinct roles and providing insights into the intricate molecular mechanisms governing CC's onset and progression. A growing body of evidence strongly suggests that circRNAs can serve as valuable biomarkers for early CC detection and hold potential as therapeutic targets for intervention. By delving into the complex interplay between circRNAs and CC, we are paving the way for innovative, individualized approaches to combat this serious disease, with the goal of reducing its impact on women's health globally and improving patient outcomes. As our understanding of circRNAs in the context of CC continues to deepen, the outlook for breakthroughs in diagnosis and treatment becomes increasingly promising.

Keywords: Biomarker; CC; Mechanism; Oncogenesis; Therapy; circRNAs.

Publication types

Review